A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study

被引：0
|
作者：
Y Nakai
H Isayama
T Sasaki
N Sasahira
T Tsujino
N Toda
H Kogure
S Matsubara
Y Ito
O Togawa
T Arizumi
K Hirano
M Tada
M Omata
K Koike
机构：
[1] Graduate School of Medicine,Department of Gastroenterology
[2] The University of Tokyo,Department of Gastroenterology
[3] Mitsui Memorial Hospital,Department of Gastroenterology
[4] Kanto Central Hospital,Department of Gastroenterology
[5] Japanese Red Cross Hospital,Department of Gastroenterology
[6] JR Tokyo General Hospital,Department of Gastroenterology
[7] Teikyo Chiba Medical Center,undefined
[8] Yamanashi Prefectural Hospital Organization,undefined
来源：
British Journal of Cancer | 2012年 / 106卷
关键词：
chemotherapy; gemcitabine; pancreatic cancer; randomised controlled trial; S-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1934 / 1939
页数：5
相关论文
共 50 条
  • [1] A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study
    Nakai, Y.
    Isayama, H.
    Sasaki, T.
    Sasahira, N.
    Tsujino, T.
    Toda, N.
    Kogure, H.
    Matsubara, S.
    Ito, Y.
    Togawa, O.
    Arizumi, T.
    Hirano, K.
    Tada, M.
    Omata, M.
    Koike, K.
    BRITISH JOURNAL OF CANCER, 2012, 106 (12) : 1934 - 1939
  • [2] A phase II trial of gemcitabine, S-1 and LV combination therapy in patients with advanced pancreatic cancer
    Saito, K. O.
    Nakai, Y.
    Isayama, H.
    Ishigaki, K.
    Saito, T.
    Takahara, N.
    Mizuno, S.
    Kogure, H.
    Koike, K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [3] The final analysis of a multicenter randomized controlled trial of gemcitabine (G) alone versus gemcitabine and S-1 combination therapy (GS) in patients with unresectable advanced pancreatic cancer (PC): GEMSAP study
    Isayama, H.
    Nakai, Y.
    Sasaki, T.
    Sasahira, N.
    Hirano, K.
    Tsujino, T.
    Tada, M.
    Omata, M.
    Koike, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer
    Saito, Kei
    Isayama, Hiroyuki
    Nakai, Yousuke
    Takahara, Naminatsu
    Ishigaki, Kazunaga
    Takeda, Tsuyoshi
    Hakuta, Ryunosuke
    Saito, Tomotaka
    Uchino, Rie
    Kishikawa, Takahiro
    Hamada, Tsuyoshi
    Mizuno, Suguru
    Sasaki, Takashi
    Kogure, Hirofumi
    Matsubara, Saburo
    Yamamoto, Natsuyo
    Ijichi, Hideaki
    Tateishi, Keisuke
    Tada, Minoru
    Koike, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (02) : 338 - 344
  • [5] A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer
    Kei Saito
    Hiroyuki Isayama
    Yousuke Nakai
    Naminatsu Takahara
    Kazunaga Ishigaki
    Tsuyoshi Takeda
    Ryunosuke Hakuta
    Tomotaka Saito
    Rie Uchino
    Takahiro Kishikawa
    Tsuyoshi Hamada
    Suguru Mizuno
    Takashi Sasaki
    Hirofumi Kogure
    Saburo Matsubara
    Natsuyo Yamamoto
    Hideaki Ijichi
    Keisuke Tateishi
    Minoru Tada
    Kazuhiko Koike
    Investigational New Drugs, 2019, 37 : 338 - 344
  • [6] Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
    Hunho Song
    Boram Han
    Choong Kee Park
    Jong Hyeok Kim
    Jang Yong Jeon
    In-Gyu Kim
    Hyo Jung Kim
    Joo Young Jung
    Jung Han Kim
    Jung Hye Kwon
    Geundoo Jang
    Ho Young Kim
    Hyeong Su Kim
    Dae Ro Choi
    Dae Young Zang
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 845 - 852
  • [7] Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
    Song, Hunho
    Han, Boram
    Park, Choong Kee
    Kim, Jong Hyeok
    Jeon, Jang Yong
    Kim, In-Gyu
    Kim, Hyo Jung
    Jung, Joo Young
    Kim, Jung Han
    Kwon, Jung Hye
    Jang, Geundoo
    Kim, Ho Young
    Kim, Hyeong Su
    Choi, Dae Ro
    Zang, Dae Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (04) : 845 - 852
  • [8] A phase 1 trial of GSL (gemcitabine, S-1, LV) combination therapy in advanced pancreatic cancer
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Saito, Kei
    Takahara, Naminatsu
    Mizuno, Suguru
    Hamada, Tsuyoshi
    Miyabayashi, Koji
    Yamamoto, Keisuke
    Kogure, Hirofumi
    Yamamoto, Natsuyo
    Hirano, Kenji
    Ijichi, Hideaki
    Tateishi, Keisuke
    Tada, Minoru
    Koike, Kazuhiko
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [9] Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial
    不详
    LANCET ONCOLOGY, 2008, 9 (01): : 39 - 44
  • [10] Phase I study of gemcitabine and S-1 combination therapy in patients with advanced pancreatic cancer
    Ueno, H
    Okusaka, T
    Ikeda, M
    Takezako, Y
    Morizane, C
    Furuse, J
    Ishii, H
    Nagase, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 353S - 353S
12345